SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Morgan Stanley Maintains Overweight on Alnylam Pharmaceuticals, Raises Price Target to $162

Morgan Stanley maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Overweight and raises the price target from $148 to $162.

Benzinga · 05/07/2020 11:31

Morgan Stanley maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Overweight and raises the price target from $148 to $162.